Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories has informed that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended September 30, 2017, with the United States Securities and Exchange Commission on November 8, 2017.

The above information is a part of company’s filings submitted to BSE.